ASELAGE STEVE 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Jun 9, 2022
Insider Transaction Report
Form 4
ASELAGE STEVE
Director
Transactions
- Award
Automatic Stock Option Grant
2022-06-07+30,022→ 30,022 totalExercise: $10.79From: 2023-06-07Exp: 2032-06-07→ Common Stock (30,022 underlying) - Award
Common Stock
2022-06-07+12,866→ 46,594 total
Footnotes (2)
- [F1]Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (the "Director Compensation Policy"), which will vest on the first anniversary of the date of grant.
- [F2]Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy.